Kira Bellamy
Nurse Practitioner · Washington, PANPI 1255085809
Payments from drug & device makers
Across 723 payments — averaging $21.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Madrigal Pharmaceuticals$1K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Pfizer$796
- plus $4K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 207 | $5,026 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 99 | $1,723 |
| Madrigal Pharmaceuticals | 66 | $1,413 |
| Johnson & Johnson | 71 | $1,394 |
| Takeda Pharmaceuticals U.S.A., Inc. | 59 | $1,044 |
| Pfizer | 38 | $796 |
| Ardelyx, Inc. | 32 | $725 |
| Phathom Pharmaceuticals, Inc. | 23 | $660 |
| Sanofi | 14 | $479 |
| QOL Medical, LLC | 11 | $298 |
| Gilead | 8 | $269 |
| Ironwood Pharmaceuticals, Inc | 18 | $260 |
| Ipsen Biopharmaceuticals, Inc | 9 | $252 |
| Braintree Laboratories, Inc. | 11 | $204 |
| Organon | 10 | $199 |
| Merck | 7 | $153 |
| E.r. Squibb & Sons, L.L.C. | 1 | $113 |
| Lilly USA, LLC | 6 | $108 |
| Intercept Pharmaceuticals, Inc. | 5 | $101 |
| Aimmune Therapeutics, Inc. | 5 | $100 |
| Bristol Myers Squibb | 4 | $80 |
| Novo Nordisk | 3 | $64 |
| Fresenius Kabi USA, LLC | 3 | $62 |
| Amgen | 2 | $54 |
| Redhill Biopharma Inc. | 2 | $42 |
| Sandoz | 2 | $38 |
| Celltrion USA Inc. | 1 | $34 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Alfasigma USA, Inc. | 2 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Vivus LLC | 1 | $16 |
How this compares
$15,781 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Washington
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
- Nicole WaetzmanStrafford$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.